Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Hodgkin lymphoma is a cancer. Like other cancers, it starts when cells grow out of control, multiplying and crowding other normal cells.
Hodgkin lymphoma starts in the lymph system, which contains the lymph nodes. The lymph system is part of the body’s immune system that protects it from infections and diseases.
Lymph nodes contain the lymph fluid that carries white blood cells through a network of thin tubes spreading through the body.
Hodgkin differs from other lymphomas in an important way: Hodgkin cancer cells only make up a small part of the cells in a lymph node. The rest of the cells are normal cells. (In other lymphomas, cancer cells make up most of the cells in a lymph node.)
Hodgkin lymphoma can usually be cured if it is found early and treated soon.
What to Expect
The Lymphoma Program specializes in the diagnosis and treatment of all types of lymphoma, including Hodgkin lymphoma.
As you and your family prepare for your care at Stanford, you’ll likely have many questions. We are here to help you in any way we can and to partner with you before, during and after treatment.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.